More from news02:37Purchasers snap up every residence in the $40 million Siarn Palm Beach North10 hours ago02:37International architect Desmond Brooks selling luxury beach villa1 day ago2 Anglers Esp, Runaway Bay.There is something attention-grabbing wherever you look– from limestone walls and recycled timber beams in the living areas to the inverted pyramid ceiling and polished floors.“The front door is from Morocco and the outdoor sink, it was a rice washing sink from Indonesia that we converted,” Ms Quinn told the Bulletin when the house first hit the market.“I’d say I’ve got eclectic taste and it really creates a home out of a house.”The four-bedroom house had been on the market with different agencies since June, 2015. It had a price tag of $5 million.Savills Qld agent Lisa Halpin negotiated the sale to a Gold Coast buyer. 2 Anglers Esp, Runaway Bay. 2 Anglers Esp, Runaway Bay sold for $4.85 million.AN ECLECTIC Gold Coast mansion on the market for a year and half has sold for $4.85 million.The Runaway Bay property at 2 Anglers Esplanade was owned by Vee Quinn.Mrs Quinn and husband Tom own OzKleen, are the force behind the Shower Power brand.They used the wealth it generated to build their dream home overlooking the Broadwater at Runaway Bay. 2 Anglers Esp, Runaway Bay. 2 Anglers Esp, Runaway Bay.
Six drug companies that are accused in thousands of lawsuits for their part in the nation’s opioid epidemic have failed to reach a settlement with governments across the country, setting the stage for a trial to begin on Monday.The six defendants in the case include three pharmaceutical distribution companies — AmerisourceBergen, Cardinal Health, and McKesson Corporation — as well as a distributor called Henry Schein Medical, generic drug company Teva Pharmaceuticals, and pharmacy chain Walgreens, court documents reveal.Discussions lasting more than 10 hours took place between CEOs of the four distribution companies, attorneys general from Tennessee, North Carolina, Pennsylvania and Texas, and lawyers representing over 2,000 state, local and Native American tribal governments.Plaintiff attorneys Paul Handly, Jr., Paul Farrell, Jr., and Joe Rice said in a joint statement, “Our goal when assessing settlement proposals is to provide local communities with adequate and urgently needed relief in the near term, and to ensure that these resources will be directed exclusively toward efforts to abate the opioid epidemic. The facts will show that opioid makers and distributors conspired to create and benefit from the worst public health crisis in decades.”Talks also took place last week with AmerisourceBergen, Cardinal Health, McKesson Corporation, Teva Pharmaceuticals, and Johnson & Johnson, to potentially settle for $50 billion, according to a source close to the matter. However, the companies proposed to pay a combined $18 billion over a course of 18 years.Purdue Pharma has already reached a proposed settlement agreement in the litigation. The company also filed for chapter 11 bankruptcy protection on September 16.